while nonmalignant lung diseases ( bronchopneumonia and chronic bronchitis ) do not interfer in the stage i with the drop of pyrrole-2-carboxylic acid excretion , in stage iii of lung cancer the decrease is less pronounced and can not be differentiated from that found in bronchopneumonia or chronic bronchitis .
C0024109
lung
C0242379
of lung cancer